Valuation: Yuhan Corporation

Market Cap 5,743B 4.27B 3.82B 3.51B 3.18B 5.98B 405B 6.13B 41.84B 16.83B 214B 16.03B 15.69B 677B P/E 2026 *
42.7x
P/E 2027 * 28.1x
Enterprise Value 5.67B 4.22M 3.77M 3.46M 3.14M 5.91M 400M 6.05M 41.33M 16.63M 211M 15.84M 15.5M 669M EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.21x
Free-Float
59.15%
Yield 2026 *
0.74%
Yield 2027 * 0.75%
1 day+1.05%
1 week-5.75%
Current month+2.53%
1 month+3.91%
3 months+4.76%
6 months-15.94%
Current year-31.49%
1 week 73,200
Extreme 73200
82,500
1 month 69,000
Extreme 69000
89,800
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 57,142.86
Extreme 57142.857142
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 75 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 A Buy

Chairperson

200 0.0002%
6/25/25 A Buy

Chief Executive Officer

720 0.0009%
6/24/25 A Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-5.75%-34.75%+35.88% 4.23B
-0.11%+9.94%+57.20%+148.21% 1,257B
-1.62%-0.95%+42.90%+75.88% 651B
-0.98%-0.14%+34.93%+102.23% 510B
-1.56%-1.39%+51.02%+64.18% 388B
-2.49%+2.01%+75.38%+39.94% 366B
-0.02%+3.15%+32.47%+55.33% 303B
-0.72%+7.05%+10.34%+32.79% 288B
-0.90%+2.97%+55.67%+70.93% 252B
-1.68%+5.27%+37.21%+105.26% 211B
Average -0.99%+4.10%+36.24%+73.06% 423.09B
Weighted average by Cap. -0.84%+5.30%+47.17%+93.09%

Financials

2026 *2027 *
Net sales 2,355B 1.75B 1.57B 1.44B 1.31B 2.45B 166B 2.51B 17.16B 6.9B 87.58B 6.58B 6.43B 278B 2,549B 1.9B 1.69B 1.56B 1.41B 2.65B 180B 2.72B 18.57B 7.47B 94.79B 7.12B 6.96B 300B
Net income 134B 99.4M 88.8M 81.57M 74.08M 139M 9.42B 143M 974M 392M 4.97B 373M 365M 15.75B 202B 150M 134M 123M 112M 210M 14.24B 216M 1.47B 592M 7.52B 564M 552M 23.83B
Net Debt -70.68B -52.57M -46.96M -43.14M -39.18M -73.58M -4.98B -75.43M -515M -207M -2.63B -197M -193M -8.33B -111B -82.37M -73.59M -67.6M -61.39M -115M -7.8B -118M -807M -325M -4.12B -309M -303M -13.05B
Projected Income Statement - Annual - Yuhan Corporation
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
03/11/26 ₩77,000.00 +1.05% 144,877
02/11/26 ₩76,200.00 +1.46% 197,715
30/10/26 ₩75,100.00 +0.54% 265,984
29/10/26 ₩74,700.00 -3.36% 317,305
28/10/26 ₩77,300.00 -3.38% 346,139
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Yuhan Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
77,000.00KRW
Average target price
112,058.82KRW
Spread / Average Target
+45.53%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yuhan Corporation
  1. Stock Market
  2. Stocks
  3. A000100 Stock